The results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk of contracting MDR-TB in children younger than 5 who had a household exposure. This is one of the first successful trials for prevention of MDR-TB. Read more here.
top of page
Recent Posts
See AllA recent study on the incidence of MDR-TB in children and teens revealed that the prevalence has resurged. there was a 10 year drop from...
The Stop TB Partnership announced a major price reduction on bedaquiline. The cost per treatment course was slashed by over 50%,...
The shutdown and dismantling of USAID has had large ramifications for TB services. As one of the largest funding sources for TB, the...
bottom of page
تعليقات